HUBEI PROVINCE, CHINA -- (MARKET WIRE) -- December 14, 2006 -- Applied Spectrum Technologies, Inc. (OTCBB: APSP) (to be known as Benda Pharmaceutical, Inc. [the "Company" or "Benda"]), a Chinese-based pharmaceutical company engaged in the development, manufacturing and distribution of medicines, active pharmaceutical ingredients and pharmaceutical intermediaries, announced today that on December 12, 2006, the Company filed a Preliminary 14C with the Securities and Exchange Commission. Following the mandatory 10-day waiting period and barring any comments from the SEC, the Company anticipates it will file a Definitive 14C on or about December 22, 2006. Following the mandatory 20-day waiting period, the Definitive 14C will become effective on or about January 11, 2007.
